Cancer Discovery

eISSN: 2159-8290pISSN: 2159-8274

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
19.6
Eigenfactor
0.05 - 0.1
H-Index
209
Impact Factor
>= 25
Scite Index
0.92 5-Year SI
SJR
Q1Oncology
SNIP
4.44

Journal Specifications

Overview
  • Publisher
    AMER ASSOC CANCER RESEARCH
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Cancer
Mutant
Immunotherapy
Lung cancer
Senescence
Glioblastoma
Overall survival
Epidermal growth factor receptor
DNA damage
Breast cancer
Prostaglandin
Progression-free survival
Tumor growth
Serine
Lymphoma
Chimeric antigen receptor
Immunization
Gene expression
Tumor microenvironment
Immune checkpoint

Recently Published Papers

Year-wise Publication

FAQs

Since when has Cancer Discovery been publishing? Faqs

The Cancer Discovery has been publishing since 2011 till date.

How frequently is the Cancer Discovery published? Faqs

Cancer Discovery is published Monthly.

What is the H-index. SNIP score, Citescore and SJR of Cancer Discovery? Faqs

Cancer Discovery has a H-index score of 209, Citescore of 19.6, SNIP score of 4.44, & SJR of Q1

Who is the publisher of Cancer Discovery? Faqs

The publisher of Cancer Discovery is AMER ASSOC CANCER RESEARCH.

How can I view the journal metrics of Cancer Discovery on editage? Faqs

For the Cancer Discovery metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Cancer Discovery? Faqs

The eISSN number is 2159-8290 and pISSN number is 2159-8274 for Cancer Discovery.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Mutant, Immunotherapy, Lung cancer, Senescence, Glioblastoma, Overall survival, Epidermal growth factor receptor, DNA damage, Breast cancer, Prostaglandin, Progression-free survival, Tumor growth, Serine, Lymphoma, Chimeric antigen receptor, Immunization, Gene expression, Tumor microenvironment, Immune checkpoint.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.